Skip to main navigation
Skip to search
Skip to main content
UTMB Health Research Expert Profiles Home
Help & FAQ
Home
Experts
Departments
Equipment
Projects/Grants
Publications
Activities
Press/Media
Honors
Impacts
Search by expertise, name or affiliation
Benign call rate and molecular test result distribution of ThyroSeq v3
N. Paul Ohori
, Michael S. Landau
, Sally E. Carty
, Linwah Yip
, Shane O. LeBeau
, Pooja Manroa
, Raja R. Seethala
, Karen E. Schoedel
, Marina N. Nikiforova
, Yuri E. Nikiforov
Research output
:
Contribution to journal
›
Article
›
peer-review
54
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Benign call rate and molecular test result distribution of ThyroSeq v3'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Molecular Diagnostics
100%
ThyroSeq
100%
Rate Test
100%
Benign Call Rate
100%
Suspicious for Malignancy
28%
Rule-out Test
28%
Risk Assessment
14%
Malignancy
14%
Clinical Management
14%
Molecular Markers
14%
Negative Predictive Value
14%
Cytopathology
14%
Histologic
14%
KRAS mutation
14%
Cytological Diagnosis
14%
Diagnostic Categories
14%
Thyroid Fine-needle Aspiration
14%
Medullary Carcinoma
14%
Parathyroid Carcinoma
14%
Indeterminate Diagnosis
14%
Benign Cytology
14%
Follicular Lesion of Undetermined Significance
14%
Genomic Classifier
14%
Medicine and Dentistry
Call Rate
100%
Cancer
50%
Clinical Management
16%
Cytotechnology
16%
Cytopathology
16%
Fine-Needle Aspiration
16%
Medullary Carcinoma
16%
Parathyroid Carcinoma
16%
Molecular Marker
16%